LCM
SANA icon

Laurion Capital Management’s Sana Biotechnology SANA Stock Holding History

Laurion Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20,000
Closed -$669K – 925
2021
Q1 		$669K Buy
+20,000
New +$651K ﹤0.01% 548

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Laurion Capital Management's SANA Position: Q2 2021 in Review

Laurion Capital Management sold out of Sana Biotechnology (SANA) in Q2 2021, closing a stake of 20,000 shares — an estimated $669K sold.

Laurion Capital Management first reported a position in SANA in Q1 2021 and held it in 1 quarter. The position peaked at $669K in Q1 2021. 80 funds tracked by Wall St. Rank hold SANA as of Q2 2021.

  • Laurion Capital Management reported no remaining Sana Biotechnology position as of Q2 2021 after selling out during the quarter.
  • Laurion Capital Management sold 20,000 Sana Biotechnology shares in Q2 2021, an estimated $669K.
  • Laurion Capital Management first reported a position in Sana Biotechnology in Q1 2021 and held it in 1 quarter.
  • Laurion Capital Management's Sana Biotechnology position peaked at $669K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2021.

Based on Laurion Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.